New Drug R&D

Pitavastatin Calcium Tablets

Product Name: Pitavastatin Calcium
Dosage Forms: Tablet
Strengths: 2 mg
Mechanism of Action:
Pitavastatin competitively inhibits HMG-CoA reductase, which is a rate-determining enzyme involved with biosynthesis of cholesterol, in a manner of competition with the substrate so that it inhibits cholesterol synthesis in the liver. As a result, the expression of LDL-receptors followed by the uptake of LDL from blood to liver is accelerated and then the plasma TC decreases. Further, the sustained inhibition of cholesterol synthesis in the liver decreases levels of very low density lipoproteins.
It is indicated as an adjunctive therapy to diet to reduce elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and to increase HDL-C in adult patients with primary hyperlipidemia or mixed dyslipidemia.
Status: Has received the acceptance notification in December, 2013.
Processing Number: CYHS1301902、CYHS1301903
Copyright @ Beijing Hope Pharmaceutical Co., Ltd.